In Front of and Behind the Replication Fork: Bacterial Type IIA Topoisomerases

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2010 Feb 19

PMID 20165898

Citations 36

Authors

Claudia Sissi

Manlio Palumbo

Affiliations

Soon will be listed here.

Abstract

Topoisomerases are vital enzymes specialized in controlling DNA topology, in particular supercoiling and decatenation, to properly handle nucleic acid packing and cell dynamics. The type IIA enzymes act by cleaving both strands of a double helix and having another strand from the same or another molecule cross the DNA gate before a re-sealing event completes the catalytic cycle. Here, we will consider the two types of IIA prokaryotic topoisomerases, DNA Gyrase and Topoisomerase IV, as crucial regulators of bacterial cell cycle progression. Their synergistic action allows control of chromosome packing and grants occurrence of functional transcription and replication processes. In addition to displaying a fascinating molecular mechanism of action, which transduces chemical energy into mechanical energy by means of large conformational changes, these enzymes represent attractive pharmacological targets for antibacterial chemotherapy.

Citing Articles

Escherichia coli DNA replication: the old model organism still holds many surprises.

Lazowski K, Woodgate R, Fijalkowska I FEMS Microbiol Rev. 2024; 48(4).

PMID: 38982189 PMC: 11253446. DOI: 10.1093/femsre/fuae018.

Interactions between Gepotidacin and Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting.

Oviatt A, Gibson E, Huang J, Mattern K, Neuman K, Chan P ACS Infect Dis. 2024; 10(4):1137-1151.

PMID: 38606465 PMC: 11015057. DOI: 10.1021/acsinfecdis.3c00346.

Friend or Foe: Protein Inhibitors of DNA Gyrase.

Ruan S, Tu C, Bourne C Biology (Basel). 2024; 13(2).

PMID: 38392303 PMC: 10886550. DOI: 10.3390/biology13020084.

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection.

Zhao X, Feng J, Zhang J, Han Z, Hu Y, Shao H Acta Pharm Sin B. 2023; 13(12):4945-4962.

PMID: 38045053 PMC: 10692473. DOI: 10.1016/j.apsb.2023.08.030.

Telling Your Right Hand from Your Left: The Effects of DNA Supercoil Handedness on the Actions of Type II Topoisomerases.

Jian J, Osheroff N Int J Mol Sci. 2023; 24(13).

PMID: 37446377 PMC: 10342825. DOI: 10.3390/ijms241311199.

References

Wang J . DNA topoisomerases: from a laboratory curiosity to a subject in cancer chemotherapy. NCI Monogr. 1987; (4):3-6. View

Wentzell L, Maxwell A . The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex. J Mol Biol. 2000; 304(5):779-91. DOI: 10.1006/jmbi.2000.4266. View

Drlica K, Zhao X . DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997; 61(3):377-92. PMC: 232616. DOI: 10.1128/mmbr.61.3.377-392.1997. View

Huang W . Bacterial diversity based on type II DNA topoisomerase genes. Annu Rev Genet. 1996; 30:79-107. DOI: 10.1146/annurev.genet.30.1.79. View

Dorman C, Corcoran C . Bacterial DNA topology and infectious disease. Nucleic Acids Res. 2008; 37(3):672-8. PMC: 2647292. DOI: 10.1093/nar/gkn996. View

BAIRD C, Harkins T, Morris S, Lindsley J . Topoisomerase II drives DNA transport by hydrolyzing one ATP. Proc Natl Acad Sci U S A. 1999; 96(24):13685-90. PMC: 24125. DOI: 10.1073/pnas.96.24.13685. View

Schoeffler A, Berger J . DNA topoisomerases: harnessing and constraining energy to govern chromosome topology. Q Rev Biophys. 2008; 41(1):41-101. DOI: 10.1017/S003358350800468X. View

Williams N, Maxwell A . Locking the DNA gate of DNA gyrase: investigating the effects on DNA cleavage and ATP hydrolysis. Biochemistry. 1999; 38(43):14157-64. DOI: 10.1021/bi991478m. View

Ali J, Jackson A, HOWELLS A, Maxwell A . The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs. Biochemistry. 1993; 32(10):2717-24. DOI: 10.1021/bi00061a033. View

10.

Fass D, Bogden C, Berger J . Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands. Nat Struct Biol. 1999; 6(4):322-6. DOI: 10.1038/7556. View

11.

Williams N, HOWELLS A, Maxwell A . Locking the ATP-operated clamp of DNA gyrase: probing the mechanism of strand passage. J Mol Biol. 2001; 306(5):969-84. DOI: 10.1006/jmbi.2001.4468. View

12.

Vologodskii A . Theoretical models of DNA topology simplification by type IIA DNA topoisomerases. Nucleic Acids Res. 2009; 37(10):3125-33. PMC: 2691845. DOI: 10.1093/nar/gkp250. View

13.

Critchlow S, Maxwell A . DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex. Biochemistry. 1996; 35(23):7387-93. DOI: 10.1021/bi9603175. View

14.

Kato J, Nishimura Y, Imamura R, Niki H, Hiraga S, Suzuki H . New topoisomerase essential for chromosome segregation in E. coli. Cell. 1990; 63(2):393-404. DOI: 10.1016/0092-8674(90)90172-b. View

15.

ODea M, Tamura J, Gellert M . Mutations in the B subunit of Escherichia coli DNA gyrase that affect ATP-dependent reactions. J Biol Chem. 1996; 271(16):9723-9. DOI: 10.1074/jbc.271.16.9723. View

16.

Stone M, Bryant Z, Crisona N, Smith S, Vologodskii A, Bustamante C . Chirality sensing by Escherichia coli topoisomerase IV and the mechanism of type II topoisomerases. Proc Natl Acad Sci U S A. 2003; 100(15):8654-9. PMC: 166367. DOI: 10.1073/pnas.1133178100. View

17.

Roca J, Berger J, Harrison S, Wang J . DNA transport by a type II topoisomerase: direct evidence for a two-gate mechanism. Proc Natl Acad Sci U S A. 1996; 93(9):4057-62. PMC: 39486. DOI: 10.1073/pnas.93.9.4057. View

18.

Wiener J, Gomez L, Venkatesan H, Santillan Jr A, Allison B, Schwarz K . Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains. Bioorg Med Chem Lett. 2007; 17(10):2718-22. DOI: 10.1016/j.bmcl.2007.03.004. View

19.

HEDDLE J, Barnard F, Wentzell L, Maxwell A . The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action. Nucleosides Nucleotides Nucleic Acids. 2000; 19(8):1249-64. DOI: 10.1080/15257770008033048. View

20.

Peng H, Marians K . The interaction of Escherichia coli topoisomerase IV with DNA. J Biol Chem. 1995; 270(42):25286-90. DOI: 10.1074/jbc.270.42.25286. View